Related Experiment Video
Updated: Jul 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
[The Danish Heart Registry--a clinical database]
Steen Zabell Abildstrøm1, Marie Kruse, Søren Rasmussen
1Københavns Universitet, Statens Institut for Folkesundhed, Arhus Universitetshospital, Skejby. stabil@dadlnet.dk
30-day mortality after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) depended on patient condition, not the treatment center. This finding highlights the importance of patient factors in cardiac procedure outcomes.
Area of Science:
- Cardiovascular medicine
- Clinical epidemiology
- Health services research
Context:
- The Danish Heart Registry (DHR) collects data on major cardiac procedures including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
- Assessing procedural outcomes and variations in care is crucial for quality improvement in cardiovascular surgery.
- Understanding 30-day mortality rates provides a key indicator of immediate post-procedural safety and effectiveness.
Purpose:
- To analyze 30-day mortality rates following PCI and isolated CABG procedures in Denmark.
- To investigate the relationship between patient characteristics, procedure indications, and 30-day mortality.
- To compare 30-day mortality across different treatment centers for PCI and CABG.
Summary:
- 30-day mortality after PCI varied significantly by indication: STEMI (6.8%), non-STEMI/unstable angina (1.9%), and stable angina (0.5%).
- 30-day mortality after isolated CABG (2.6%) was closely associated with the EuroSCORE risk stratification tool.
- No significant differences in 30-day mortality were observed between the five participating centers for either primary PCI or isolated CABG.
Impact:
- Findings indicate that patient condition and procedural indication are primary drivers of short-term mortality, rather than variations in center-specific practices.
- This study provides valuable data for quality benchmarking and identifying areas for targeted clinical intervention.
- The results support the use of risk stratification tools like EuroSCORE in CABG and emphasize the need to consider indication-specific outcomes in PCI evaluations.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

